Correlation Between Akari Therapeutics and Sigilon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Sigilon Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Sigilon Therapeutics.
Diversification Opportunities for Akari Therapeutics and Sigilon Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Akari and Sigilon is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Sigilon Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Sigilon Therapeutics
If you would invest 98.00 in Akari Therapeutics PLC on October 26, 2024 and sell it today you would earn a total of 24.00 from holding Akari Therapeutics PLC or generate 24.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.56% |
Values | Daily Returns |
Akari Therapeutics PLC vs. Sigilon Therapeutics
Performance |
Timeline |
Akari Therapeutics PLC |
Sigilon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akari Therapeutics and Sigilon Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akari Therapeutics and Sigilon Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |